Back to Search
Start Over
POSC280 Economic Evaluation of Nivolumab Plus Ipilimumab in Advanced Renal-Cell Carcinoma in Japan
- Source :
- Value in Health. 25:S188-S189
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Health Policy
Public Health, Environmental and Occupational Health
Subjects
Details
- ISSN :
- 10983015
- Volume :
- 25
- Database :
- OpenAIRE
- Journal :
- Value in Health
- Accession number :
- edsair.doi...........4d284bf2eb1c2638829e436083f84edd
- Full Text :
- https://doi.org/10.1016/j.jval.2021.11.917